Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas

PURPOSE: Gene-targeting therapy provides a novel therapeutic approach for tumor treatment using genetically modified endothelial progenitor cells (EPCs) as cellular carriers. This study applied EPCs armed with cytosine deaminase (CD) and endostatin (ES) fusion gene in liver cancer to explore its the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue-Lin, Zhou, Tan-Yang, Ai, Jing, Chen, Sheng-Qun, Chen, Feng, Nie, Chun-Hui, Chen, Xin-Hua, Zhou, Guan-Hui, Wang, Hong-Liang, Zhu, Tong-Yin, Wang, Bao-Quan, Yu, Zi-Niu, Jing, Li, Wu, Li-Ming, Zheng, Shu-Sen, Sun, Jun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198450/
https://www.ncbi.nlm.nih.gov/pubmed/32431545
http://dx.doi.org/10.2147/CMAR.S245998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198450/
https://www.ncbi.nlm.nih.gov/pubmed/32431545
http://dx.doi.org/10.2147/CMAR.S245998

Ejemplares similares